Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Mayne Pharma Group ( (AU:MYX) ) is now available.
First Sentier Investors Holdings Pty Limited, a member of MUFG, has issued a correction regarding the date of a notifiable change in its interest in Mayne Pharma Group Ltd (MYX). Initially reported on 6 June 2025, the correct date of the change is 5 June 2025. This adjustment in reporting ensures accurate disclosure of investment activities, which is crucial for maintaining transparency and trust with stakeholders.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 980,618
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$429.8M
For detailed information about MYX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue